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ABSTRACT 
Forty percent of the population worldwide is at risk of malarial infections. Approximately 
200 million cases of malaria occur annually, resulting in over 400,000 deaths in 2015, the most 
heavily impacted demographic being children under the age of five. Plasmodium falciparum, 
responsible for 99% of deaths, has an organelle called the apicoplast, not found in mammals and 
most other eukaryotic organisms. The apicoplast must reproduce (and duplicate its own genome) 
in order for Plasmodium to sustain infections. Efforts in the discovery of new anti-malarial drugs 
target the duplication of the apicoplast genome, specifically an apicoplast-specific DNA 
polymerase (hereafter apPOL), which exhibits low sequence identity to other know polymerases, 
including those found in humans and bacteria. Inhibition of DNA polymerases has led to 
effective treatments of viral infections (HIV, herpes simplex virus, hepatitis B virus, and 
cytomegalovirus), indicating an inhibitor of apPOL might be useful in the treatment of malaria.  
Structures of crystalline complexes of apPOL could facilitate the development of potent 
inhibitors; however, in order to provide structural information, suitable crystals must be available 
in quantity.  Reported here are conditions that support the growth of large single crystals of 
apPOL.  Crystal structures reveal binding sites for hydrated lithium cations and sulfate anions, 
and suggest mechanisms by which these ligands support the growth of large single crystals.  
Sulfate anions map to the polymerase active site and editing site; however, well-define sulfate 
anions also map to sites without a known function.  2-Methyl-2,4-pentandiol could stabilize 
crystals, whereas dimethyl sulfoxide disrupts polymerase conformation and stability
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CHAPTER I INTRODUCTION 
General Introduction 
Malaria is caused by a parasite carried by mosquitos, and has represented a global health 
problem for humans throughout history. More than 40% of the population worldwide is at risk of 
contracting malaria. The World Health Organization reported in 2010 that the 219 million cases 
of malaria resulted 660 thousand deaths [1]. The majority of fatalities were children under the 
age of five. In 2015, the World Health Organization reported 212 million cases leading to 429 
thousand deaths, with 303 thousand being children under five years of age [2].  Although 
substantial progress was made from 2010 to 2015 in reducing deaths (child-death due to malaria 
decreased by 29%), malaria kills children in Africa at a rate of one for every two minutes. The 
most common treatment for malaria is artemisinin and its derivatives, but in 2005 resistance to 
artemisinin by Plasmodium falciparum, the most common causative agent of malaria in humans, 
emerged in Southeast Asia (specifically, five countries in the Greater Mekong sub-region) [2]. 
Resistant strains of the pathogen will spread worldwide, threatening recent progress made toward 
eradicating the disease. New drugs will be necessary in order to meet the goal of disease 
eradication by 2030. 
Five species of Plasmodium cause malaria in humans: Plasmodium falciparum, 
Plasmodium vivax, Plasmodium malariae, Plasmodium ovale and Plasmodium knowlesi. The 
first four are transmitted to humans by mosquitoes, the last through contaminated water [3].  P. 
falciparum represents the largest threat to human health, causing 99% of the 429 thousand deaths 
due to Plasmodium infections [2]. After transmission from mosquito to human, the parasite 
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(sporozoites stage) infects liver cells and undergoes replication [4]. After one cycle of 
replication, the infected liver cell (liver schizont) bursts, releasing merozoites that infect red 
blood cells. Merozoites replicate in the red blood cell, forming after 48 hours a red blood cell 
shizont, which bursts releasing more merozoites into the blood stream.  The destruction of red 
blood cells and release of merozoites cause symptomatic peaks of fever and anemia associated 
with malaria [5]. Some merozoites mature to the gametocyte stage.  Subsequent mosquito 
predation results in the transfer of gametocytes from human to the gut of the mosquito, where 
gametocytes develop into first microgametes, then macrogametes and finally zygotes.  Zygotes 
migrate out of the mosquito gut, develop into oocysts, which burst and release sporozoites ready 
for infection of a human (or another mammalian) host. 
 Plasmodium species are members of the phylum Apicomplexa [5]. Most apicomplexans 
have a four-membrane plastid called the apicoplast. Genetic analysis supports the evolution of 
the apicoplast from the chloroplast of red algae. Putatively, a secondary endosymbiotic event 
resulted in the capture of red algae by a primordial predecessor of Plasmodium [6]. Over time, 
the captured chloroplast lost its photosynthetic capabilities, but retained (or acquired) and 
evolved metabolic pathways for fatty acid, isoprenoid and heme synthesis, as well as Fe–S 
cluster maturation. The apicoplast is essential for the replication of the parasite.  Daughter 
merozoites without apicoplast do not undergo further cell division. In fact, loss of the apicoplast 
results in the “delayed-death” of the parasite in both the liver and red-blood cell stage of an 
infection [7]. The parasite survives but daughter cells are unable to sustain an infection. Because 
of its presence in a single phylum (which includes many organisms responsible for infectious 
disease) and because of its essential role in sustaining parasite reproduction, the apicoplast is a 
potential target in the development of anti-malarial drugs [7]. 
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Approximately 600 proteins reside within the apicoplast. Eight percent are involved in 
translation, 1% in transcription and 4% in DNA replication. Inhibition of DNA polymerases has 
led to effective treatments of HIV, herpes simplex virus, hepatitis B virus, and cytomegalovirus 
[8].  Hence, inhibition of the DNA polymerase responsible for the duplication of the genome of 
the apicoplast seems a reasonable strategy.  Replication of the apicoplast genome involves a 
DNA polymerase, helicase, primase, single-stranded DNA binding protein, DNA gyrase and 
ligase. All are promising targets for the development of anti-malarial drugs. In fact, 
ciprofloxacin, an inhibitor of the apicoplast topoisomerase (gyrase), has anti-malaria activity [9]. 
PfPREX (Plasmodium falciparum plastidic DNA replication/repair enzyme complex) is a 
polyprotein translated in the cytoplasm of Plasmodium and imported to the apicoplast. PfPREX 
is 235 kDa and contains concatenated sequences similar to a DNA primase, helicase and 
polymerase separated by spacers [10]. PfPREX, N-terminally labeled with green fluorescent 
protein, accumulates in the apicoplast of P. falciparum [10]. Moreover, as the polymerase and 
primase subunits of PfPREX have no direct orthologues in mammalian cells, these authors 
maintain that these two enzymes might be fruitful targets in the development of new drugs. The 
DNA polymerase component of PfPREX, hereafter called apPOL, bears low sequence identity 
(20–30%) to A-family DNA polymerases found in the thermophilic bacteria of the phylum 
Aquificae and to the Klenow fragment of Escherichia coli [11-12].  The nearest homolog outside 
Apicomplexa is the cyanobacteria Cyanothece sp. PCC 8802 replication polymerase (35% 
sequence identity) [13]. Of all polymerases in humans, the nearest to apPOL is the lesion bypass 
polymerase theta with 23% identity and nu with 22% identity. As the apicoplast DNA 
polymerases of P. vivax and P. falciparum are 84% identical [14], an effective drug against P. 
falciparum might be effective against all strains of Plasmodium that infect humans. 
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A-Family polymerases, of which apPOL is an example, come predominantly from 
bacteria, but also from mitochondria, the nucleus of eukaryotes and some bacteriophage [15]. 
Bacterial DNA polymerases often elongate Okazaki fragments, remove RNA primers during 
replication, and repair DNA. Such polymerases employ a 5ʹ to 3ʹ polymerase domain, a 3ʹ to 5ʹ 
exonuclease proofreading domain, and a 5ʹ to 3ʹ exonuclease domain for primer removal and 
DNA repair [15,16]. Structures of A-family polymerases are available for the Klenow fragment 
from Escherichia coli Polymerase I (Klenow), the large fragment of the DNA polymerase from 
Bacillus stearothermophilus (BF), and the DNA polymerases from bacteriophage T7 (T7), 
Thermus aquaticus (Taq), and mitochondria (DNA pol𝛾) [17–19], as well as two low-fidelity 
eukaryotic A-family polymerases that reside in the nucleus [20-21].  Each resembles a right hand 
with finger, palm, and thumb subdomains [Figure 1]. The palm subdomain is well-conserved, 
whereas the finger and thumb subdomains diverge across species [22]. The 3ʹ to 5ʹ exonuclease 
domains are poorly conserved except for three amino acid motifs at or near the exonuclease 
active site [23]. 
Although crystal structures are available, the reproducible growth of suitable crystals and 
the successful cryoprotection of crystals for data collection represent major challenges.  N-
terminal polyhistidyl-tagged apPOL provided only small crystals (<5 µm), and only 1 in 300 
crystals provided usable X-ray diffraction data after freezing in liquid nitrogen [24].  C-terminal 
polyhistidyl-tagged apPOL provides non-twinned crystals of size 20 µm that more readily retain 
crystalline order upon freezing [24]; however, the production of two crystal structures in as many 
years is an unfavorable rate of progress when confronted with the prospect of investigating 
several hundred polymerase-inhibitor complexes in the context of a drug discovery effort.  The 
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 Figure 1. Architecture and subdomains of apPOL.  Adapted from reference [24] 
 purpose of experimental work here is the determination of conditions that (i) lead to the rapid, 
reproducible growth of large single crystals of apPOL, (ii) conditions that allow reproducible, 
rapid freezing of crystals in liquid nitrogen with retention of crystalline order and (iii) an 
evaluation of the effects of small-molecule organic solvents on crystalline properties.  Efforts 
here have provided improved conditions of crystallization, leading to the rapid growth of crystals 
as large as 200 µm.  Hydrated lithium alone and in combination with sulfate anions increase the 
rate of crystallization, and the terminal size of crystals.  Of the aqueous-organic solvent systems 
investigated (acetonitrile, t-butanol, dimethyl sulfoxide and 2-methyl-2,4-pentandiol), crystals 
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tolerated only 2-methyl-2,4-pentandiol to a concentration of 5% (v/v).  The results here limit 
protocols for the introduction of inhibitors into pre-formed crystals of apPOL in favor of co-
crystallization of apPOL-inhibitor complexes.  In addition, the basis for the stabilizing effects of 
lithium and sulfate, and destabilizing effects of dimethyl sulfoxide is revealed by the analysis of 
structures of apPOL presented here.  
Thesis Outline 
Chapter I of this thesis provides general background information. Chapter II is written in 
a format self-contained and suitable for publication.  It presents optimized conditions for 
crystallization and cryoprotection, as well as multiple structures that reveal roles played by 
hydrated lithium complexes and sulfate anions in the stabilization of crystals. Chapter III 
summarizes the major findings and suggest directions for future research. 
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CHAPTER II 
OPTIMIZATION OF CRYSTALS FOR SCREENING INHIBITORS OF THE DNA 
POLYMERASE FROM THE APICOPLAST OF PLASMODIUM FALCIPARUM 
 
Abstract 
Malaria in humans, primarily caused by the parasite Plasmodium falciparum, is a 
mosquito-borne disease causing more than 400,000 deaths annually. Parasites emerging in 
central Africa, India, Southeast Asia, and northern South America exhibit increasing resistance to 
antimalarial drugs. Malaria vaccines under development have yet to provide broad protection to 
vulnerable populations. Hence new, potent antimalarial drugs will likely play a central role in the 
control and eventual eradication of the disease.  Plasmodium falciparum contains a plastid called 
the apicoplast. The apicoplast is absent in humans but necessary for parasite survival. Substances 
that poison the essential functions of the apicoplast, could serve as drugs for the treatment of 
malaria. The DNA polymerase of the apicoplast (apPOL) governs an essential function (DNA 
synthesis in support of apicoplast reproduction) and is a target of drug screening efforts.  In order 
to use the current crystal form of the polymerase in drug screens, the crystallization protocol 
must be optimized in order to produce numbers of large single crystals.  The introduction of 
lithium and sulfate ions in crystallization buffers has led to a 10-fold increase in size of crystals, 
and the consistent production of crystals suitable for X-ray data collection.  The role of sulfate 
anions and hydrated lithium cations in the stabilization of crystals has been revealed by through 
multiple structure determinations. 
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Introduction 
Malaria is a common disease carried by mosquitos. Based on the World Health 
Organization, malaria causes about 200 million infections and 429,000 deaths in 2015[1]. About 
¾ of all deaths are of children 5 years of age and younger. About 40% of the world population is 
living at risk of malaria, especially those in Africa and Southeast Asia. Increased resistance to 
anti-malarial drugs has emerged in central Africa, India, Southeast Asia and South America. [1] 
In humans, Plasmodium falciparum is the leading cause of malarial infections.  In the 
2016 World Malaria Report, 99% of the 429 thousand deaths in 2015 are caused by P. falciparum 
[1]. P. falciparum is a member of phylum Apicomplexa [2]. Most organisms in Apicomplexa 
have a four-membrane organelle called the apicoplast, which is thought to be evolved from the 
secondary endosymbiosis of the chloroplast of red algae [3]. The apicoplast has its own genome 
and is involved in fatty acid biosynthesis, isoprenoid synthesis, heme synthesis, and Fe–S cluster 
maturation. Loss of the apicoplast results in a “delayed death” phenotype in which the daughter 
cells that lack apicoplasts are nonviable [4].  Thus, the biochemical system responsible for 
apicoplast reproduction is a target for the development of new antimalarial drugs.  
Approximately 600 proteins reside within the apicoplast and around 8% are involved in 
translation, 1% in transcription, 3% in DNA replication. Research shows [5-7] that a Type A 
family DNA polymerase (apPOL) is imported to the apicoplast and used in the replication of its 
genome.  The nearest A-family homolog of apPOL outside of the phylum Apicomplexa is the 
replication polymerase from the cyanobacteria Cyanothece sp. PCC 8802 (35% sequence 
identity) [8]. In humans, there are three Type A family polymerases, the nearest to apPOL is the 
lesion bypass polymerase theta with 23% identity and nu with 22% identity. On the other hand, 
apPOL is 84% sequence-identical to the apicoplast DNA polymerase of Plasmodium vivax [9]. 
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Drugs effective against apPOL from P. falciparum might also work against other causative 
agents for malaria.  
Although crystal structures are available, the reproducible growth of suitable crystals and 
the successful cryoprotection of crystals for data collection represent major challenges.  N-
terminal polyhistidyl-tagged apPOL provided only small crystals (<5 µm), and only 1 in 300 
crystals provided usable X-ray diffraction data after freezing in liquid nitrogen [10].  C-terminal 
polyhistidyl-tagged apPOL provides non-twinned crystals of size 20 µm that more readily retain 
crystalline order upon freezing [11]; however, the production of two crystal structures in as many 
years is an unfavorable rate of progress when confronted with the prospect of investigating 
several hundred polymerase-inhibitor complexes in the context of a drug discovery effort.  The 
purpose of experimental work here is the determination of conditions that (i) lead to the rapid, 
reproducible growth of large single crystals of apPOL, (ii) conditions that allow reproducible, 
rapid freezing of crystals in liquid nitrogen with retention of crystalline order and (iii) an 
evaluation of the effects of small-molecule organic solvents on crystalline properties.  Efforts 
here have provided improved conditions of crystallization, leading to the rapid growth of crystals 
as large as 200 µm.  Hydrated lithium alone and in combination with sulfate anions increase the 
rate of crystallization, and the terminal size of crystals.  Of the aqueous-organic solvent systems 
investigated (acetonitrile, t-butanol, dimethyl sulfoxide and 2-methyl-2,4-pentandiol), crystals 
tolerated only 2-methyl-2,4-pentandiol to a concentration of 5% (v/v).  The results here limit 
protocols for the introduction of inhibitors into pre-formed crystals of apPOL in favor of co-
crystallization of apPOL-inhibitor complexes.  In addition, the basis for the stabilizing effects of 
lithium and sulfate, and destabilizing effects of dimethyl sulfoxide, are revealed by the analysis 
of apPOL structures presented here. 
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Materials and Methods 
Materials. Oligodeoxynucleotides used for directed mutation came from the Iowa State 
University DNA Facility. Ni-NTA-agarose came from QIAGEN.  Crystal Screen sets I and II 
were from either Fisher or Hampton Research.  PEG 6000 was purchased from Hampton 
Research.  All other chemicals were reagent grade.  
Mutation of exonuclease-inactive (apPOLexo−) into wildtype polymerase (apPOL). 
apPOLexo−, which has a double mutation to its exonuclease active site (D82N and E84Q), was the 
basis of kinetics and structural work on apPOL [11-12]. Work here employed wild-type apPOL, 
obtained by Quickchange [BIO-RAD] mutagenesis of the plasmid for apPOLexo− (E. coli pet28b) 
into wild-type apPOL [10]. The forward primer sequence used in mutagenesis was 5’-
GACATCAAATACTGTGGTCTGGATATTGAAACCACGGGCCTGGAAGTC-3’ 
(N82D/Q84E) where the codons responsible for mutation in bold typeface.  The reverse primer 
sequence was the reverse complement of the forward primer.  The mutations were confirmed by 
sequencing the DNA of the final construct at the Iowa State University DNA Facility. 
Protein expression and purification. E. coli BL21 cells were transformed with the 
plasmid (E. coli pet28b) containing the insert for the wild-type DNA polymerase from the 
apicoplast of P. falciparum with a C-terminal polyhistidyl tag. After incubation at 37	℃, a single 
colony was picked from an LB/kanamycin agar plate, and then used in the inoculation of 200 mL 
LB medium with kanamycin (30 µg/mL).  After modest shaking for 16 hrs. at 37 ℃, 10 mL 
aliquots of the overnight culture were added to 1 L flasks containing 800 mL of LB with 
kanamycin (30 µg/mL). Flasks were incubated at 37 ℃ with shaking (225 rpm) until A600 
reached 0.6. Flasks were cooled to 18 ℃ by transfer to a cold room, after which isopropyl 1-thio-
b-D-galactopyranoside was added to a concentration of 0.2 mM.  After an additional 16 hrs. with 
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shaking (225 rpm) at 18 ℃, cells were collected by centrifugation at 4000 rpm for 30 minutes. 
The cell pellet was re-suspended in 20 mM Tris-HCl, 500 mM NaCl and 5 mM imidazole, pH 
8.0 and passed through an EmulsiFlex-C3 homogenizer at least 3 times at 30,000 psi. The cell 
lysate was centrifuged at 17000 rpm at 4℃ for 50 minutes. 
 The supernatant loaded onto a 3 mL Ni-NTA-agarose column. The column was washed 
with 100 mL of 20 mM Tris-HCl, 500 mM NaCl and 5 mM imidazole, pH 8.0 followed by 100 
mL of 20 mM Tris-HCl, 1 M NaCl, 15 mM imidazole, pH 8.0. After checking A260/A280 at the 
end of the high-salt wash to verify removal of oligonucleotides from the sample, the protein was 
eluted with 20 mM Tris-HCl, 200 mM NaCl, 150 mM imidazole, pH 8.0. Protein eluted with the 
first 30 mL of buffer (monitored by Bradford assay).  Pooled fractions were loaded onto a 
TOYOPEARL HW-50F (150 mL) gravity column (TOSOH), equilibrated with 20 mM Tris-HCl, 
400 mM NaCl, pH 8.0. Each fraction was checked by Nano drop to determine those containing 
protein. Pooled fractions were concentrated to 10 mg/mL and passed through a 0.22 µm filter.  
Freshly prepared protein was used in crystallization experiments.  
Crystallization and Data collection.  Starting crystallizations employed Crystal Screen, 
Crystal Screen 2 and Index from Hampton Research by the method of hanging-drops. apPOL in 
20 mM Tris-HCl, 400 mM NaCl, pH 8.0 was combined with well solutions at a ratio of 1:1, 
producing a droplet of 4 µL. Crystallization trays were maintained at room temperature. Efforts 
to stabilize and enhance crystal growth involved the addition of metal cations (Li+, Mg2+, Mn2+, 
Ca2+) and sulfate anions.  Crystals were dipped in aqueous-organic solvents (acetonitrile, t-
butanol, dimethyl sulfoxide and 2-methyl-2,4-pentandiol) made (v/v) from 95% well solution 
and 5% pure organic component. Immediately after dipping, crystals were plunged into liquid 
nitrogen. 
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X-Ray diffraction data were collected at Argonne National Laboratory, Advanced Photon 
Source, beamlines 23-ID-B and 23-ID-D at 100 K using a crystal-to-detector distance of 400 
mm, an exposure time of 2.0 s, oscillation width of 1° and beam size of 20 µm. Data were 
processed by HKL-3000, using a cutoff on spurious negative intensities (sigma cutoff -1) and 
using a resolution cut-off that retained data up to and including a high-resolution shell with 
<I>/<sigma-I> of ~1.  Experience in the refinement of previous structures of apPOL [11] 
indicated data to a resolution of <I>/sigma<I> of 0.8 afforded reasonable statistics and improved 
refinement outcomes. 
Although unit cell dimensions were reasonably consistent amongst data sets, direct 
refinement of the model PDBID:5DKU (C-terminal His tagged apPOLexo−) resulted in high 
initial R-values, that slowly fell to acceptable levels.  For the sake of computational efficiency, 
structures for each data set were re-determine by molecular replacement (resulting TFZ values 
out of PHENIX-PHASER ranging from 50 to 95), the output models from which refined 
(PHENIX-REFINE) in two cycles to R-free and R-work values of approximately 0.25.  User 
supplied restraints (approximately 700 in total) on donor-acceptor distances maintained 
consistently good stereochemistry for all models.  The solvent structure for each model was 
developed independently by the addition of sulfate anions, hydrated lithium, and bound 
molecules of MES, DMSO and MPD as appropriate, on the basis of the composition of 
crystallization droplets and the interpretation of difference electron density maps.  Sulfate anion 
assignments to electron density were confirmed by the initial refinement of water molecules, 
which resulted in unreasonably low B-values, net positive difference density and distances in 
excess of 3.5 Å from potential proton donors.  Hydrated lithium complexes were assigned to 
electron density if all other alternatives failed (multiple water molecules, sulfate, DMSO and 
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MPD). Available data sets afforded several checks of consistency in the assignment of ligands to 
electron density: (1) As two apPOL molecules are in the asymmetric unit, sites for sulfate anions 
and aquo-lithium cations should appear in pairs, exceptions coming at the interfaces between 
protein molecules. (2) PDBID:5DKU has no sulfate, no lithium and no organic component; 
electron density assigned to sulfate, aquo-lithium cations and organic molecules must be absent 
in 5DKU.  (3) All data sets here come from crystals grown in the presence of sulfate, however, 
some crystals have grown in the absence of lithium.  (4) Usable data came from crystals with 2-
methyl-2,4-pentandiol (MPD) or dimethyl sulfoxide (DMSO). 
 
 
Results 
The protein is abundant in the cell-free extract (Fig. 1) and was at least 95% pure after 
size exclusion chromatography (Fig. 2). Results of data collection and refinement appear in Table 
1.  All crystals dipped in DMSO and MPD provided data in the resolution range of 3.0 to 3.5 Å, 
and behaved comparably in refinement.  Crystals dipped in t-butanol and acetonitrile either 
exhibited no diffraction (acetonitrile) or very poor diffraction (t-butanol) (Table. 2). Efforts here 
focus on crystals exposed to MDP and DMSO.  
Sulfate anions and their binding sites on apPOL appear in Table 3 and Fig. 3.  The 
identification of sulfate anions benefitted from the crystal structure PDBID:5DKU, which lacked 
sulfate, Li+, and organic small molecules.  The majority of sites in Table 3 appear in both 
molecules of apPOL in the asymmetric unit. On the basis of crystallographic criteria alone, 
sulfate anion binding is most robust at Site-701 (Fig. 3).  Here, B-values for atoms of SO42− at 
100% occupancy refine to values comparable to that of surrounding atoms of the protein (~50 
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Å2).  Electron density associated with Sites 702−718 have lower electron density reflecting 
occupancies of approximately 80%.  (Occupancy values were adjusted manually to result in an 
approximate match of the B-values of anion and protein atoms).  Sites 710, 713 and 717, 
however, map to probable locations for the binding of phosphoryl groups of dNTPs, Site 704, 
705, 706, 711, 712 map to primer DNA or template DNA (Table 3).  Site 718, is in a groove lined 
by lysine residues between polymerase and exonuclease domains on a face of the polymerase 
opposite that of its two active sites. Finally, Sites 707, 714 and 716 are between molecules of the 
asymmetric unit or at lattice contacts, and may represent interactions due to the crystal packing 
environment. Sulfate anions, however, do not determine the packing of protein molecules in the 
crystal, as crystals of identical space group and nearly identical unit cell dimensions 
(PDBID:5DKU) grow in the presence and absence of the sulfate anion. 
Crystallization conditions that included the lithium cation as LiCl or Li2SO4 (250 mM) 
caused rapid group of crystals of apPOL (generally, less than 24 hours) to a terminal size 
averaging 200 µm.  Other metal cations (Mg2+, Mn2+, Ca2+ and Zn2+) at concentrations of 
approximately 100 mM either produced small crystals or none at all. The reproducible and 
specific effect of the lithium cation on crystal growth suggests an interaction involving the 
protein. 
After the initial round of refinement, crystals grown in the presence of the Li+ exhibited 
significant electron density and difference electron density in a void separating the two 
polymerase molecules in the asymmetric unit of the crystal (Fig. 4).  The centroids of these 
spheres of electron density were far (>3.5 Å) from the nearest donor/acceptor atom.  B-values for 
single water molecules at these sites refined to single digits and low teens, when surrounding 
atoms from the protein have B values of approximately 70 Å2.  Sulfate and dimethyl sulfoxide 
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(DMSO) refined at these locations resulted in B values for the sulfur atom in excess of 200 Å2.  
The region has several residues with either positive or negative electrostatic charge (Asp240 
A&B, Asp 561 A&B, Lys 244 A&B) with a net overall charge that is negative. Electron density 
spheres of the kind observed in structures which included Li+, were absent in structures that 
excluded the lithium cation from the crystallization conditions.  Given these observations, we 
assigned hydrated Li+ complexes to each of the spheres. 
The structure of the hydrated lithium complex is not known with certainty.  Neutron 
diffraction studies of lithium salts in water indicate 5.5±0.3 molecules of water coordinate to 
each Li+, in reasonable agreement with the estimate of 5 water molecules per cation indicated by 
observed rates of diffusion [13]. Ion transport and mobility experiments indicate >13 water 
molecules associated with each Li+  [14-18]. Presumably, the higher numbers reflect the count of 
water molecules in both the inner coordination sphere of the cation as well as the less structured 
secondary sphere.  We refined two kinds of hydrated lithium complexes against crystallographic 
data: [Li(H2O)4]+ and [Li(H2O)6]+, the former with tetrahedral symmetry and the latter with 
octahedral symmetry.  Atoms of the tetrahydro-lithium cation refined to B-values of 
approximately 50 Å2, about 10−20 Å2 less than that of atoms of the surrounding protein.  
Moreover, the oxygen atoms of [Li(H2O)4]+ were still distant from potential donor/acceptor side 
chains of the protein.  B-values of [Li(H2O)6]+ match those of the surrounding protein, and 
oxygen atoms make reasonable hydrogen bonds with side chains from the protein.  The refined 
model, and associated electron density for 4 of 7 density spheres assigned to [Li(H2O)6]+, 
appears in Fig. 5.  Hydrogen-bonding residues in proximity to each complex cation are given in 
Table 4.  All sites assigned to a complex lithium cation are between the two molecules in the 
asymmetric unit (Fig. 6).  In PDBID:5DKU the same region exhibits difference electron density, 
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consistent with disorganized water.  In the MES/DMSO/Ca2+ complex (sulfate present), low 
electron difference density in this intermolecular space eliminates sulfate as a contributing factor.  
Indeed, one would not expect a sulfate binding side juxtaposed to acidic side chains of aspartate 
as documented in Table 4. 
Crystals exposed to DMSO exhibited diffraction to a resolution comparable to crystals 
exposed to MPD or no organic solvent, but then decayed rapidly in the X-ray beam, limiting the 
amount of useable data (Table 2).  We would hope to see an effect due to DMSO on lattice 
contacts in the crystals or on the polymerase, and in fact, we observe a consistent conformational 
change in the polymerase when DMSO is present (MES/DMSO/Ca2+ and MES/DMSO/Li+). In 
all structures determined from crystals exposed to DMSO the side chain of Trp512 has rotated 
out of the hydrophobic core of the polymerase domain into the solvent (Fig. 7), and a ball of 
density appears in the resulting cavity.  In all other structures of apPOL (for instance, 
PDBID:5DKU or 5DKT) Trp512 packs into the hydrophobic core.  This clear instance of 
conformational change in response to DMSO suggests the likelihood of DMSO-liked 
destabilization of apPOL.   
In contrast, a binding site for MPD appears near Trp512, when the side chain of Trp512 
packs into its hydrophobic core.  Interestingly, crystals dipped in MPD may have extended 
lifetimes in the X-ray beam.  Moreover, the proposed MPD binding site and the exposed (non-
packed) conformation of Trp512 are mutually exclusive, suggesting antagonistic effects of 
DMSO and MPD, the former destabilizing and the later stabilizing the polymerase.  MPD could 
have a cryo-protective role; however, further study is necessary to confirm this. 
Electron difference density appeared in PDBID:5DKT in the vicinity of Lys27 and 
Arg52, however, difference density was not adequately explained by manipulation of the protein 
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conformation.  Comparable electron difference density was absent in PDBID:5DKU, providing 
evidence for a molecule of bound MES, and with work here, reproducible difference electron 
density appears in all other crystals grown in the presence of MES.  The MES binding site and its 
electron density appear in Figs 8&9.  The sulfonyl group of MES binds to the side chain of 
Arg52 and the oxygen atom of the morpholino group of MES hydrogen bonds to the backbone 
amide nitrogen of Lys27. 
 
 
Discussion 
The sulfate anion at Site-701 is likely associated with some functional aspect of the 
polymerase.  If sites of lower occupancy (and arguably lower affinity for sulfate) represent 
binding sites for phosphoryl groups of the substrate (dNTP) or primer/template DNA, then the  
highest affinity site for sulfate is not likely an artifact of crystallography.  Most notably, if one 
extends the template strand at its 5'-end relative to the 3'-end of the primer, the second additional 
phosphodiester linkage could reach sulfate Site-701 when the primer/template DNA is in the 
putative editing mode of the polymerase (Fig. 10).  This hypothetical role for Site-701 as a 
recognition site for template DNA when primer DNA occupies the exonuclease site could be 
tested by mutation.  Elimination of Site-1 through the introduction of a bulky side chain can be 
verified by a crystal structure determination.  The anticipated impact on polymerase function 
would be the loss of pause-edit kinetics and/or a significant loss in polymerase fidelity.  This site 
could also be of interest in the development of drugs that impact P. falciparum replication by 
compromising the genomic “health” of the apicoplast. 
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The possibility of lithium hydration complexes between the two polymerase molecules of 
the asymmetric unit is possibly the first instance of such complexes reported in a crystallographic 
structure.  There are no instances of lithium hydration complexes in the Protein Data Bank, 
although there exist structures which report the lithium cation bound directly to side chains of the 
protein.  “Naked” lithium cations in water are improbable, however, and most certainly protein-
bound Li+ would be subject to multiple interactions with side chains and/or water molecules. 
With but two electrons in its 1s orbital, Li+ by itself would be invisible in structures of less than 
atomic resolution; its existence inferred only by the proximity of 4 to 6 oxygen atoms without the 
possibility of donor-acceptor (hydrogen) bonding.  The only plausible interpretations of 
difference electron density in the MES/DMSO/Li+ and MES/MPD/Li+ complexes reported here 
are (1) multiple water molecules localized, but disordered, by multiple hydrogen-bonding 
configurations or (2) multiple water molecules localized through mutual interactions with Li+.  
We prefer the latter interpretation, on the basis of electron difference density, which is enhanced 
whenever Li+ is part of the crystallization medium.  When Li+ is absent the low electron density 
between polymerase molecules is due to quasi-organized water molecules. 
Given that a single Li+ influences 13 or more molecules of water (ion transport and 
mobility data), a 4 M solution of Li+ will influence all water molecules (55 M) in solution.  The 
void between the two molecules of the polymerase is fully occupied by [Li(H2O)6]+ in our 
models of the MES/DMSO/Li+ and MES/MPD/Li+ complexes, suggesting that Li+ could have a 
cryo-protective influence.  The sequestration of water molecules by Li+ could well prevent the 
disruptive effects of ice-crystal formation in voids of the crystal.  The use of small organic 
molecules in part was in the interest of finding cryo-protective agents; however, Li+ even at 200 
21 
 
mM may be the key cryo-protective agent with the organic component (DMSO or MPD) having 
little or no positive effect. 
Whether the binding of MES to the polymerase implies a functional significance is 
unclear.  The MES molecule binds to the N-terminal region (NTR) of the polymerase, a region 
well conserved in amino acid sequence amongst apicoplast polymerases, but absent in other A-
family polymerases.  The NTR has no assigned function, but others have speculated on a 
possible role in the binding of DNA [11]. Given the mapping of sulfate anions to substrate and 
DNA binding sites, the sulfonyl group of MES may again map to a functional site that recognizes 
an extended DNA molecule (single-stranded template or duplex template/primer). 
DMSO has been the solvent of choice for the lead molecule MMV666123 in the 
antimalarial drug development. DMSO at 5% (v/v) does not impact the kinetics of the 
polymerase, but experiments in kinetics require DNA primer/template, which may stabilize 
polymerase conformation.  Crystallography, however, is best done with the apo-form of the 
polymerase, which would reveal competitive and noncompetitive inhibitors.   Given the 
destabilizing effects of DMSO on the polymerase in crystals, future work on inhibitor–
polymerase complexes should focus on co-crystallization of polymerase and inhibitor.  In a co-
crystallization experiment, the polymerase would solubilize the inhibitor, and the resulting 
complex crystallized under conditions that result in robust crystal growth.  Such conditions are 
now known, and the magic element that facilitates that growth is the lithium cation. 
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Tables 
Table 1: Statistics of data collection and refinement.  Values associated with the high-resolution shell are in 
parentheses.  
 (PDBID: 
5DKT) 
(PDBID: 
5DKU) 
CA2+/DM
SO 
LI+/MPD LI+/DMSO 
RESOLUTION 
RANGE 
47.36 - 
2.90 
47.90 - 2.90 50 - 3.40 50 - 3.20 50 - 3.00 
SPACE GROUP P6522 P65 P65 P65 P65 
UNIT CELL a=b=141.7, 
c=148.76 
a=b=146.38, 
c=165.67 
a=b=143.3
, c=165.89 
a=b=145.8, 
c= 165.89  
a=b=145.4, 
c= 165.28  
REFLECTIONS 
USED 
19,696 44,271 21,912 32,961 40,087 
MOSAICITY   0.63-0.91 0.59-0.90 0.39-0.68 
PERCENT 
COMPLETENE
SS 
97.8 (96.4) 99.3 (98.6) 86.8(89.1) 99.8(99.0) 99.3 (98.7) 
MEAN 
I/SIGMA(I) 
3.4(0.8) 14.9 (2.2) 4.37(1.00) 8.87 (1.16) 8.17 (0.86) 
R-SYMM 0.345 0.094 0.14 0.153 0.143 
R-MEAS   0.174 0.168 0.167 
RPIM   0.101 0.069 0.085 
R-WORK 0.27 0.19 0.24 0.2 0.21 
R-FREE 0.3 0.23 0.27 0.23 0.24 
CC1/2 0.338(0.02) 0.110(0.60) 0.983(0.46
) 
0.991(0.42
) 
0.992(0.31
) 
REDUNDANC
Y 
4.3(3.4) 3.5(3.2) 2.4(2.3) 5.8(5.0) 3.6(3.2) 
NO. OF ATOMS      
   PROTEIN 4800 9665 9635 9623 9664 
   WATER 63 96 26 71 12 
   LIGAND 46 2 127 222 200 
RMS(BONDS) 0.003 0.002 0.003 0.003 0.003 
RMS(ANGLES) 0.548 0.477 0.446 0.422 0.448 
RAMACHAND
RAN FAVORED 
(%) 
92 95.5 91.7 94.1 94.3 
AVERAGE B 
(Å2) 
     
   PROTEIN 17 59 87 84 69 
   WATER 32 54 33 57 40 
   LIGAND 23 83 103 92 95 
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Table 2. The lifetime of crystals dipped in 5% (v/v) organic-aqueous solvent systems. Lifetime calculated by 
average number of frames used for each data collection times the frame exposure time (2 sec). R-merge is 
determined at limiting resolutions of 4, 3.5 and 3 Å resolution. TFZ is the translation function Z-score resulting from 
the molecular replacement solution using data to the limiting resolution indicated to the right. 
Puck 
ID 
Cation/orga
nic 
component 
Frame
s used 
Rmerge at 4, 3.5 and 
3 (Å) resolution 
TFZ Resoluti
on used 
Average 
lifetime (sec) 
P2-1 Li/MPD 61 0.06
4 
0.087 0.12
3 
71.3 3 
95.5*2=191 
P2-2 Li MPD 131 0.09
7 
0.131 0.18
1 
53.6 3 
P2-9 Li/MPD 110 0.07
1 
0.099 0.14
3 
68 3 
P2-10 Li/MPD 80 0.12
7 
0.165 0.23
5 
63.8 3.5 
         
P2-4 Li/DMSO 61 0.09 0.122 0.18
4 
34.8 3 
47.75*2=95.5 
P2-11 Li/DMSO 30 0.09 0.124 0.18
7 
59.8 3 
P2-12 Li/DMSO 40 0.11 0.161 0.26
2 
54.8 3.5 
P3-13 Li/DMSO 60 0.09
1 
0.117 0.16
7 
86.1 3 
         
P2-14 Li/t-Butanol 40 0.13
4 
0.197 0.31
8 
58 3.5 40*2=80 
P2-13 Li/t-Butanol - - - - - - weak 
diffraction  
P3-5 Li/t-Butanol - - - - - - weak 
diffraction  
P3-6 Li/t-Butanol - - - - - - weak 
diffraction  
         
P1-7 Li/Acetoniti
le 
- - - - - - disordered 
P1-8 Li/Acetoniti
le 
- - - - - - disordered 
P2-15 Li/Acetoniti
le 
- - - - - - disordered 
P2-16 Li/Acetoniti
le 
- - - - - - disordered 
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Table 3: SO4 binding site on Chain A and Chain B of apPOL that dipped into difference solution compared with 
known structure PDBID:5DKT. 
 
# 
SITE 5DKT Ca2+/ 
DMS-
A 
Ca2+/ 
DMS-B 
Li+/ 
MPD-
A 
Li+/ 
MPD-
B 
Li+/ 
DMS-
A 
Li+/ 
DMS-
B 
701 Leu522 NH, 
Gln523 NH, 
Gln 523NE2 
✔ ✔ ✔ ✔ ✔ ✔ ✔ 
702 Trp199 NE1 ✔ ✕ ✕ ✕ ✕ ✕ ✕ 
703 Leu178 NH, 
Gln138NE2, 
Asn139ND2 
✔ ✕ ✕ ✔ ✔ ✔ ✔ 
704 Gln387 NE2 ✔ ✔ ✕ ✔ ✔ ✔ ✔ 
705 Ser375 NH, 
Phe374 NH 
✔ ✔ ✔ ✔ ✔ ✔ ✔ 
706 Lys382 NH, 
Asn384 NH, 
Lys 352 NZ 
✔ ✔ ✕ ✔ ✔ ✔ ✔ 
707 Lys511 NZ, 
Asn424ND2   
✔ ✔ ✔ ✔ ✔ ✔ ✔ 
708 His236 N, 
Ile237 N,  
Asn 234 ND2 
✔ ✕ ✕ ✕ ✕ ✕ ✕ 
709 Lys171 NZ,  
Lys 169 NZ 
✔ ✕ ✔ ✕ ✔ ✕ ✔ 
710 Arg459 NH1, 
NH2 
✕ ✔ ✔ ✔ ✔ ✔ ✔ 
711 Arg520 NH1, 
NH2 
✕ ✔ ✔ ✔ ✔ ✔ ✔ 
712 Ser538 OG, 
Lys448 NZ  
✕ ✔ ✔ ✔ ✔ ✔ ✔ 
713 Lys463 NZ, 
His460 ND 
✕ ✕ ✔ ✕ ✔ ✕ ✔ 
714 Lys531A NZ, 
Asn433BND2, 
Asn234 B ND2 
✕ ✕ ✔ ✔ ✔ ✔ ✔ 
715 Lys192 NZ ✕ ✔ ✕ ✔ ✔ ✔ ✔ 
716 Asn435* ND2, 
Lys171 NZ, 
Lys184 NZ  
✕ ✔ ✔ ✔ ✔ ✔ ✔ 
717 HIS439 NE, 
Gln413 NE2 
✕ ✕ ✕ ✔ ✕ ✔ ✕ 
718 Lys153 NZ,  ✕ ✕ ✕ ✔ ✔ ✔ ✔ 
 *This is shows the residue site is at lattice contract.   
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Table 4.  Presence of electron density for [Li(H2O)6]+ binding sites in Chain A and Chain B of apPOL.  5DKT, 
Ca2+/DMS-A and Ca2+/DMS-B have sulfate but no lithium. For other entries lithium is present along with dimethyl 
sulfoxide (DMS) or 2-methyl-2,4-pentandiol (MPD).  
 SITE 5DKT Ca2+/ 
DMS-A 
Ca2+/ 
DMS-B 
Li+/ 
MPD-
A 
Li+/ 
MPD-
B 
Li+/ 
DMS-
A 
Li+/ 
DMS-
B 
730 Lys613 A, 
Asn234 B 
✕ ✕ ✕ ✔ ✔ ✕ ✕ 
731 Asp240  ✕ ✕ ✕ ✔ ✔ ✔ ✔ 
732 Asp561 ✕ ✕ ✕ ✔ ✔ ✔ ✔ 
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Figures  
 
Figure 1. SDS-PAGE Gel from fractions collected from the Ni-NTA column. The first column (left to 
right) represents molecular weight markers.  The second is the supernatant after centrifugation of the cell-
free lysate.  The third column is collected from the wash with 20 mM Tris-HCl, 500 mM NaCl and 5 mM 
imidazole. The fourth column is collected from the wash with 20 mM Tris-HCl, 1 M NaCl, 15 mM 
imidazole, pH 8.0. The last column is collected from the wash with 20 mM Tris-HCl, 200 mM NaCl, 150 
mM imidazole. 
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 Figure 2. SDS-PAGE Gel for fractions collected from the size exclusion column. Shown are fractions 21 
to 28, each having a Nano drop with concentration greater than 1.  The ratio of A260/A280 is above each 
band. 
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Figure 3. Sulfate binding sites on the polymerase.  Highlighted, is Site 701, which represents the highest site of 
occupancy by sulfate in all structures of the polymerase. 
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Figure 4. Omit electron density (blue) and difference density (green) after an initial round of refinement. 
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Figure 5. [Li(H2O)6]+ in electron density after refinement. 
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. 
Figure 6. Complex lithium cations are present between the two molecules of apPOL in the asymmetric unit.  
  
34 
 
 
 
Figure 7. DMSO with Trp512 rotated out of the hydrophobic core of the polymerase domain into the 
solvent   
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                 Figure 8.  MES binding site relative to the polymerase structure.  
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Figure 9.  Electron density at the MES binding site. 
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Figure 10. SO4 site 701 (yellow) and the location of primer DNA (red) and template DNA (cyan) taken from the 
putative editing complex of Klenow.  
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CHAPTER III    CONLUSIONS 
Summary 
The primary contribution to drug development efforts of the work presented here comes 
from the discovery of the lithium cation as an agent of enhanced crystal growth.    In the first 
three years of crystallographic work only two usable data sets resulted from well over 1000 
crystals mounted and probed by X-ray diffraction.  Over the past year, more than 20 data sets 
have been collected.  In the presence of Li+, crystals grow faster and larger than in the absence of 
the Li+.  The effect is specifically attributable to Li+, as other metal cations do not result in 
improved growth of crystals.  Whether Li+ by itself, or in combination with MPD, is cryo-
protective and extends crystal lifetime needs to be determined by additional investigation.  Rapid 
and reproducible growth of apPOL crystals is essential in support of efforts to investigate what 
could be more than 100 in vitro inhibitors that are likely to come out of screens of small 
molecule libraries. 
Given the instability of crystals in the presence of DMSO and other organic solvents, 
structures of inhibitor-polymerase complexes are gotten best through co-crystallization 
experiments under conditions that support robust crystal growth.  The rationale here: Optimize 
polymerase crystallization and thereby optimize crystallization of polymerase-inhibitor 
complexes. 
Unanticipated benefits of the present study come with the realization of a possible 
functional role for the primary binding site for sulfate (Site-701) that has led to a testable 
hypothesis.  Site-directed mutation, a crystal structure of the mutant in the presence of sulfate, 
and experiments in kinetics will test whether this primary site for sulfate binding plays the 
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proposed functional role in locking the template DNA into a conformation that stabilizes the 
pause-edit action of the polymerase. 
The unexpected discovery of bound MES may or may not have functional significance, 
but underscores the importance of a key hydrogen bond in enhancing specificity in the binding of 
a small molecule to a protein.  MES at 10-fold lower concentration than sulfate, goes specifically 
to the N-terminal region of the polymerase because of the single hydrogen bond of its 
morpholino group with a backbone amide of the protein. 
 
 
Further Study  
We are planning to determine whether MPD is a cryo-protectant by comparing diffraction 
from crystals of apPOL, with and without MPD, frozen in liquid nitrogen. Beside this, we are 
also interested in Site 701, which by hypothesis is a recognition site for template DNA when 
primer DNA occupies the exonuclease site. The introduction of a residue with a β-branched side-
chain, or one of negative charge by site-directed mutation should block sulfate binding. Crystal 
structures of the mutant in the presence of sulfate would confirm the success of the mutation, and 
experiments in kinetics will test whether this primary site for sulfate binding plays the proposed 
functional role in locking the template DNA into a conformation that stabilizes the pause-edit 
action of the polymerase.  
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